Suchergebnisse - "Spira, Alexander"

PubPharm (169)

31

Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer : Final Results From the Phase III ALTA-1L Study

enthalten in: Clinical lung cancer | 2022

von Ahn, M. | Kim, H. | Yang, J. | +18

32

Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001) : a phase 1/2, open-label, basket trial

enthalten in: The Lancet. Oncology | 2022

von Subbiah, V. | Wolf, J. | Konda, B. | +12

CommentIn: Lancet Oncol. 2022 Oct;23(10):1235-1237. - PMID 36108663

33

Adagrasib in Non-Small-Cell Lung Cancer. Reply

enthalten in: The New England journal of medicine | 2022

von Jänne, P. | Sabari, J. | Spira, A.

CommentOn: N Engl J Med. 2022 Sep 29;387(13):1238-1239. - PMID 36170508

34

Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors : phase 1 trial interim results

enthalten in: Nature medicine | 2022

von Palmer, C. | Rappaport, A. | Davis, M. | +41

35

Improving Cancer Care Delivery : Learnings for Oncology Nurses and Patient Navigation From a National Quality Survey

enthalten in: Journal of the advanced practitioner in oncology | 2022

von Aversano, J. | Boehmer, L. | Spira, A.

36

Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation

enthalten in: The New England journal of medicine | 2022

von Jänne, P. | Riely, G. | Gadgeel, S. | +19

CommentIn: N Engl J Med. 2022 Jul 14;387(2):180-183. - PMID 35830645

37

Author Correction : Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors

enthalten in: Investigational new drugs | 2022

von Waqar, S. | Robinson, C. | Olszanski, A. | +11

ErratumFor: Invest New Drugs. 2022 Jun;40(3):596-605. - PMID 35150356

38

Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors

enthalten in: Investigational new drugs | 2022

von Waqar, S. | Robinson, C. | Olszanski, A. | +11

ErratumIn: Invest New Drugs. 2022 Feb 28;:. - PMID 35226229

39

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

enthalten in: The New England journal of medicine | 2022

von Forde, P. | Spicer, J. | Lu, S. | +127

CommentIn: N Engl J Med. 2022 May 26;386(21):2050-2051. - PMID 35403840

40

Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors : An Open-Label Phase I/II Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Boni, V. | Fidler, M. | Arkenau, H. | +25